Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
RedHill Biopharma
RedHill Biopharma
Activities:
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Manufacturing
Recipharm extends commercial manufacturing for RedHill’s drug
Talicia is eligible for eight years of US market exclusivity under QIDP designation and its patent protection extends at least until 2034
Digestion
RedHill Biopharma announces exclusive US co-promotion agreement with Concordia for GI drug Donnatal
RedHill and Concordia have entered into an exclusive co-promotion agreement, granting RedHill certain US promotion rights for Donnatal
Manufacturing
Recipharm to manufacture Heliobacter pylori drug candidate for RedHill Biopharma
The Swedish CDMO will invest approximately SEK13m in manufacturing capabilities
Subscribe now